![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Saturday, October 30, 2010 2:36:42 PM
If the CGNH beads become the standard in a billion dollar a year market, look out! If Merck takes a 50% market share or 500 million, this results in 150 million in revenue to CGNH with only a small increase in expenses. If The result is even $2.50 a share in profit applying a modest p/e ratio for a growth company like CGNH of 20 brings us to $50 a share.
That brings us to the POC analyzer where FDA approval alone would cause a rapid appreciation of the stock price. This may happen as early as the spring.
While nothing is ever guaranteed when investing in a speculative stock like CGNH, I am willing to take the risk on this one.
Recent CGNH News
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/26/2024 04:25:43 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM